Literature DB >> 2062088

Colorectal cancer patients with high risk of hematogenous metastasis: correlation with CEA levels in peripheral and draining venous blood during the period of operation.

Y Tabuchi1, H Deguchi, K Imanishi, Y Saitoh.   

Abstract

Correlations between carcinoembryonic antigen (CEA) levels of peripheral (p) and draining (d) venous blood during the period of operation, and pre- and post-operatively detected hematogenous metastases were examined in 78 patients with colorectal cancer. The metastases were found in 28 patients (HM group), but not found in the other 50 patients (non-HM group). The mean values (43 and 198 ng/ml) and positive rates (61 and 96%) greater than 5 ng/ml of p- and d-CEA levels in the HM group were significantly higher than those (6 and 14 ng/ml, and 22 and 48%, respectively) in the non-HM group. The differences (mean 184 ng/ml and positive rate 49%) of d-CEA levels between both groups were more significant than those (39 ng/ml and 30%) of p-CEA levels. The mean value (155 ng/ml) and positive rate (82%) greater than 5 ng/ml of the gradient between d- and p-CEA levels (d-p CEA gradient) in the HM group were significantly higher than those (8 ng/ml and 34%) in the non-HM group. These results suggest that patients with a high risk of hematogenous metastases are more effectively checked by the determination of d-CEA levels and d-p CEA gradient than of p-CEA levels, and that they are patients with positive d-CEA and d-p CEA gradient levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2062088     DOI: 10.1002/jso.2930470206

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival.

Authors:  Y Tabuchi; T Nakamura; T Kuniyasu; M Ohno; S Nakae
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  The serum level of carcinoembryonic antigen in drainage venous blood is not a sensitive predictor of metachronous hepatic metastasis for patients with colorectal cancer.

Authors:  Masashi Haraguchi; Fumihiko Fujita; Yasuhiro Torashima; Takamitsu Inokuma; Yoshitsugu Tajima; Takashi Kanematsu
Journal:  Surg Today       Date:  2010-07-30       Impact factor: 2.549

3.  Role of blood tumor markers in predicting metastasis and local recurrence after curative resection of colon cancer.

Authors:  Yifan Peng; Zhiwei Zhai; Zhongmin Li; Lin Wang; Jin Gu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

4.  Suppressive effect of doxorubicin on liver recurrence after resection of colonic VX2 cancer lesions: difference in efficacy according to the injection protocol.

Authors:  M Sakane; Y Tabuchi; Y Saitoh
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.